AAAAAA
Results:
1-10
|
Results: 10
Authors:
Tatarczynska, E
Klodzinska, A
Kroczka, B
Chojnacka-Wojcik, E
Pilc, A
Citation: E. Tatarczynska et al., The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration, PSYCHOPHAR, 158(1), 2001, pp. 94-99
Authors:
Bojarski, AJ
Misztal, S
Boksa, J
Charakchieva-Minol, S
Wesolowska, A
Tatarczynska, E
Klodzinska, A
Chojnacka-Wojcik, E
Citation: Aj. Bojarski et al., Substituted 2-(1,2,3,4-tetrahydroisoquinoline)-butyl derivatives of azaspiro[4.5]decane-7,9-dione and phthalimide as new 5-HT1A and 5-HT2A receptor ligands, MED CHEM RE, 10(9), 2001, pp. 634-643
Authors:
Tatarczynska, E
Klodzinska, A
Chojnacka-Wojcik, E
Palucha, A
Gasparini, F
Kuhn, R
Pilc, A
Citation: E. Tatarczynska et al., Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist, BR J PHARM, 132(7), 2001, pp. 1423-1430
Authors:
Pilc, A
Chojnacka-Wojcik, E
Tatarczynska, E
Borycz, J
Kroczka, B
Citation: A. Pilc et al., Stimulation of group II metabotropic glutamate receptors or inhibition of group I ones exerts anxiolytic-like effects in rats, AMINO ACIDS, 19(1), 2000, pp. 81-86
Authors:
Przegalinski, E
Tatarczynska, E
Chojnacka-Wojcik, E
Citation: E. Przegalinski et al., The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats, NEUROPHARM, 39(10), 2000, pp. 1858-1864
Authors:
Mokrosz, MJ
Bojarski, AJ
Duszynska, B
Tatarczynska, E
Klodzinska, A
Deren-Wesolek, A
Charakchieva-Minol, S
Chojnacka-Wojcik, E
Citation: Mj. Mokrosz et al., 1,2,3,4-tetrahydroisoquinoline derivatives: A new class of 5-HT1A receptorligands, BIO MED CH, 7(2), 1999, pp. 287-295
Authors:
Mokrosz, MJ
Kowalski, P
Kowalska, T
Majka, Z
Duszynska, B
Bojarski, AJ
Fruzinski, A
Karolak-Wojciechowska, J
Wesolowska, A
Klodzinska, A
Tatarczynska, E
Chojnacka-Wojcik, E
Citation: Mj. Mokrosz et al., Structure-activity relationship studies of CNS agents. Part 38 - Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3-benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT1A and antagonistic 5-HT2A activities, ARCH PHARM, 332(11), 1999, pp. 373-379
Authors:
Pawlowski, M
Katlabi, J
Drabczynska, A
Duszynska, B
Charakchieva-Minol, S
Deren-Wesolek, A
Tatarczynska, E
Chojnacka-Wojcik, E
Mokrosz, MJ
Bojarski, AJ
Citation: M. Pawlowski et al., New 9- or 10-arylpiperazinoalkyl substituted pyrimido- or diazepino[2,1-f]purines with partial or full 5-HT1A agonistic activity, EUR J MED C, 34(2), 1999, pp. 167-175
Authors:
Przegalinski, E
Tatarczynska, E
Klodzinska, A
Chojnacka-Wojcik, E
Citation: E. Przegalinski et al., Tolerance to anxiolytic- and antidepressant-like effects of a partial agonist of glycine(B) receptors, PHARM BIO B, 64(3), 1999, pp. 461-466
Authors:
Deren-Wesolek, A
Tatarczynska, E
Chojnacka-Wojcik, E
Citation: A. Deren-wesolek et al., The novel buspirone analogue, 8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl)]butyl]-8-azaspiro[4.5]decane-7,9-dione, with anxiolytic-like and antidepressant-like effects in rats, J PSYCHOPH, 12(4), 1998, pp. 380-384
Risultati:
1-10
|